168 related articles for article (PubMed ID: 17074479)
1. Isoindolone derivatives, a new class of 5-HT2C antagonists: synthesis and biological evaluation.
Hamprecht D; Micheli F; Tedesco G; Checchia A; Donati D; Petrone M; Terreni S; Wood M
Bioorg Med Chem Lett; 2007 Jan; 17(2):428-33. PubMed ID: 17074479
[TBL] [Abstract][Full Text] [Related]
2. 5-HT2C antagonists based on fused heterotricyclic templates: design, synthesis and biological evaluation.
Hamprecht D; Micheli F; Tedesco G; Donati D; Petrone M; Terreni S; Wood M
Bioorg Med Chem Lett; 2007 Jan; 17(2):424-7. PubMed ID: 17079142
[TBL] [Abstract][Full Text] [Related]
3. Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines.
Bromidge SM; Dabbs S; Davies DT; Duckworth DM; Forbes IT; Ham P; Jones GE; King FD; Saunders DV; Starr S; Thewlis KM; Wyman PA; Blaney FE; Naylor CB; Bailey F; Blackburn TP; Holland V; Kennett GA; Riley GJ; Wood MD
J Med Chem; 1998 May; 41(10):1598-612. PubMed ID: 9572885
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
[TBL] [Abstract][Full Text] [Related]
5. Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: synthesis and biological evaluation.
Micheli F; Pasquarello A; Tedesco G; Hamprecht D; Bonanomi G; Checchia A; Jaxa-Chamiec A; Damiani F; Davalli S; Donati D; Gallotti C; Petrone M; Rinaldi M; Riley G; Terreni S; Wood M
Bioorg Med Chem Lett; 2006 Aug; 16(15):3906-12. PubMed ID: 16730983
[TBL] [Abstract][Full Text] [Related]
6. 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists.
Bromidge SM; Davies S; Duckworth DM; Forbes IT; Jones GE; Jones J; King FD; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Riley GJ; Trail B; Wood MD
Bioorg Med Chem Lett; 2000 Aug; 10(16):1867-70. PubMed ID: 10969987
[TBL] [Abstract][Full Text] [Related]
7. Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists.
Röver S; Adams DR; Bénardeau A; Bentley JM; Bickerdike MJ; Bourson A; Cliffe IA; Coassolo P; Davidson JE; Dourish CT; Hebeisen P; Kennett GA; Knight AR; Malcolm CS; Mattei P; Misra A; Mizrahi J; Muller M; Porter RH; Richter H; Taylor S; Vickers SP
Bioorg Med Chem Lett; 2005 Aug; 15(15):3604-8. PubMed ID: 15975787
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiinflammatory activity of heterocyclic indole derivatives.
Rani P; Srivastava VK; Kumar A
Eur J Med Chem; 2004 May; 39(5):449-52. PubMed ID: 15110970
[TBL] [Abstract][Full Text] [Related]
9. 3-Acrylamide-4-aryloxyindoles: synthesis, biological evaluation and metabolic stability of potent and selective EP3 receptor antagonists.
Zhou N; Zeller W; Zhang J; Onua E; Kiselyov AS; Ramirez J; Palsdottir G; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Mar; 19(5):1528-31. PubMed ID: 19188065
[TBL] [Abstract][Full Text] [Related]
10. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
[TBL] [Abstract][Full Text] [Related]
11. Studies towards the identification of a new generation of atypical antipsychotic agents.
Garzya V; Forbes IT; Gribble AD; Hadley MS; Lightfoot AP; Payne AH; Smith AB; Douglas SE; Cooper DG; Stansfield IG; Meeson M; Dodds EE; Jones DN; Wood M; Reavill C; Scorer CA; Worby A; Riley G; Eddershaw P; Ioannou C; Donati D; Hagan JJ; Ratti EA
Bioorg Med Chem Lett; 2007 Jan; 17(2):400-5. PubMed ID: 17084080
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT(2A/2C) receptor antagonists.
Cid J; Alonso JM; Andrés JI; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK; Trabanco AA
Bioorg Med Chem Lett; 2004 Jun; 14(11):2765-71. PubMed ID: 15125929
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
Corbett DF; Heightman TD; Moss SF; Bromidge SM; Coggon SA; Longley MJ; Roa AM; Williams JA; Thomas DR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4014-8. PubMed ID: 16002289
[TBL] [Abstract][Full Text] [Related]
14. Cyclic urea derivatives as potent NK1 selective antagonists.
Shue HJ; Chen X; Shih NY; Blythin DJ; Paliwal S; Lin L; Gu D; Schwerdt JH; Shah S; Reichard GA; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Liu F; Nomeir AA; Morgan CA; Varty GB
Bioorg Med Chem Lett; 2005 Sep; 15(17):3896-9. PubMed ID: 16019209
[TBL] [Abstract][Full Text] [Related]
15. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
[TBL] [Abstract][Full Text] [Related]
16. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds.
Severino B; Fiorino F; Perissutti E; Frecentese F; Cirino G; Roviezzo F; Santagada V; Caliendo G
Bioorg Med Chem; 2008 Jun; 16(11):6009-20. PubMed ID: 18477511
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of substituted tetrahydrocarbazole derivatives as new NPY-1 antagonists.
Di Fabio R; Giovannini R; Bertani B; Borriello M; Bozzoli A; Donati D; Falchi A; Ghirlanda D; Leslie CP; Pecunioso A; Rumboldt G; Spada S
Bioorg Med Chem Lett; 2006 Mar; 16(6):1749-52. PubMed ID: 16364642
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists.
Park CM; Kim SY; Park WK; Park NS; Seong CM
Bioorg Med Chem Lett; 2008 Jul; 18(14):3844-7. PubMed ID: 18602261
[TBL] [Abstract][Full Text] [Related]
20. 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents.
Bromidge SM; Dabbs S; Davies S; Duckworth DM; Forbes IT; Jones GE; Jones J; King FD; Saunders DV; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Riley GJ; Trail B; Wood MD
Bioorg Med Chem Lett; 2000 Aug; 10(16):1863-6. PubMed ID: 10969986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
